360° SearchNetwork Hot Spots Trends Time Series

Alogliptin

Type: Keyphrase

Name: Alogliptin

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Three New Type 2 Diabetes Treatment Options Approved in the U.S.

(BPT) - The number of people living with type 2 diabetes continues to grow. In the United States, it is estimated that approximately 23 million Americans are currently living with the disease. Type 2 diabetes is the most common form of the disease and ... [Published Record Delta - May 13 2013]

Entities: Oseni, Kazano, Nesina

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Furiex Releases 1Q 2013 Financial Results

Furiex Pharmaceuticals, Inc. has reported its financial and operating results for the quarter ended March 31. In a release on May 7, the Company recorded first quarter milestone revenues of $30.0 million. This revenue was comprised of two milestones earned ... [Published Individual.com - May 13 2013]

Entities: Furiex Pharmaceuticals, Priligy, Alogliptin, Net Income, Administrative Expenses

First reported May 11 2013 - Updated May 11 2013 - 1 reports

Which Came First? Alogliptin Avoids Possible Exclusivity Dispute

An unusual footnote in FDA’s approval letter for Takeda’s long-delayed diabetes medicine means that the company won’t have to worry about losing five-year exclusivity on the molecule. ... [Published The Rose Sheet - May 11 2013]

Entities: Alogliptin, Molecule, Diabetes

First reported May 10 2013 - Updated May 10 2013 - 3 reports

Furiex Reports First Quarter 2013 Financial Results [Manufac. . .

Furiex Reports First Quarter 2013 Financial Results [Manufacturing Close - Up]ProQuest Information & LearningFuriex Pharmaceuticals, Inc. reported its financial and operating results for the quarter ended March 31.In a release on May 7, the company noted ... [Published Equities.com - May 10 2013]

Entities: Furiex Pharmaceuticals, Priligy, Alogliptin, Net Income, Administrative Expenses

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Nycomed International Management GmbH

Takeda rides out Actos decline as fiscal 2012 sales rise

Nycomed acquisition continues to bolster revenuesJapanese pharma company Takeda posted a 3 per cent increase in revenues in the fiscal year 2012, despite the lingering effects of losing patent protection for diabetes blockbuster Actos in the US last ... [Published PMLive - May 09 2013]

Entities: Actos, Nesina, Nycomed International Management GmbH

First reported May 09 2013 - Updated May 09 2013 - 1 reports

Furiex Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript

9:00 AM ETOperatorGood day, ladies and gentlemen, and welcome to the First Quarter 2013 Earnings Release and Conference Call. [Operator Instructions] As a reminder, ladies and gentlemen, this conference is being recorded. I would now like to introduce ... [Published Seeking Alpha - May 09 2013]

Entities: Priligy, Nesina, Menarini Group, Furiex Pharmaceuticals

First reported May 07 2013 - Updated May 08 2013 - 3 reports

Takeda Pharmaceutical Co Ltd

Furiex Pharmaceuticals, Inc. (FURX) Reports First Quarter 2013 Financial Results

Staying up-to-date has never been simpler. Sign up for the today! (NASDAQ: FURX) today reported its financial and operating results for the quarter ended March 31, 2013. Furiex recorded first quarter milestone revenues of $30.0 million. This revenue was ... [Published BioSpace - May 08 2013]

Entities: Furiex Pharmaceuticals, Alogliptin, Takeda Pharmaceutical Co Ltd

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Furiex Reports First Quarter 2013 Financial Results

First Quarter 2013 Highlights:Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today reported its financial and operating results for the quarter ended March 31, 2013.Furiex recorded first quarter milestone revenues of $30.0 million. This revenue was comprised ... [Published Reuters - May 07 2013]

Entities: Furiex Pharmaceuticals, Priligy, Alogliptin, Research & Development

First reported May 03 2013 - Updated May 03 2013 - 1 reports

False Friends: FDA’s “Gift” on NESINA – Present or Poison? It May Depend on Which Hatch-Waxman Language is Spoken

By Kurt R. Karst –Frau Rommelfanger’s seventh grade German class: that’s where we first learned to appreciate “false friends,” which are pairs of words or phrases in two languages that look or sound alike, but differ significantly in meaning. Never write ... [Published FDA Law Blog - May 03 2013]

Entities: Alogliptin, Patent, Nesina

First reported May 03 2013 - Updated May 03 2013 - 1 reports

New Findings from Keio University in Diabetes Provides New Insights

(NewsRx) -- By a News Reporter-Staff News Editor at Proteomics Weekly -- Investigators publish new report on Diabetes. According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, "Dipeptidyl peptidase-4 (DPP-4) ... [Published NewsRX - May 03 2013]

Entities: Keio University, Diabetes, DPP-4

First reported Feb 04 2013 - Updated Feb 05 2013 - 3 reports

OSENI (Alogliptin And Pioglitazone) Tablet, Film Coated [Takeda Pharmaceuticals America, Inc.]

Updated Date: Feb 4, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]

Entities: Alogliptin, Takeda Pharmaceuticals U S A, Pioglitazone

First reported Jan 25 2013 - Updated Jan 26 2013 - 3 reports

Pharmacy News

Furiex Confirms Takeda’s Receipt of FDA Approval of NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the Treatment of Type 2 Diabetes MORRISVILLE, N.C.–(BUSINESS WIRE)–Furiex ... [Published Rx Times Pharmacy Magazine - Jan 26 2013]

Entities: Alogliptin, Kazano, Nesina, Pioglitazone

Quotes

Fred Eshelman, Pharm.D , chairman of Furiex, added, "Our milestone and royalty-based portfolio continues to provide an important financial foundation for our business. In the past twelve months, our collaborations have generated $77.4 million in milestone and royalty revenue and we look forward to building on this success with the launch of alogliptin related products in the U S and Priligy in regions outside of the U S "

Furiex Releases 1Q 2013 Financial Results [Published Individual.com - May 13 2013]

...According to news reporting originating from Tokyo, Japan, by NewsRx correspondents, research stated, "Dipeptidyl peptidase-4 (DPP-4) inhibitors have been reported to be generally well tolerated. However, angioedema has been reported as one of the rare adverse events of these drugs."

New Findings from Keio University in Diabetes Provides New Insights [Published NewsRX - May 03 2013]

"We are pleased to announce the collaboration with Takeda," said Fabrice Baschiera, General Manager, Pharmaceutical Operations, Sanofi China. "Alogliptin reinforces the strategic focus of Sanofi in the diabetes field. The new addition of alogliptin strengthens our offer of innovative diabetes treatment to Chinese patients, which includes best-in-class oral and insulin drugs. We look forward to working with Takeda to make alogliptin more widely available to patients with type 2 diabetes in China" added Mr. Baschiera

Takeda and Sanofi Sign Co-promotion Agreement to Expand Reach of Diabetes Treatment Alogliptin in ... [Published Nycomed News RSS feed - Apr 22 2013]

First, from the March 14, 2013 "FDA Drug Safety Communication: FDA investigating reports of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas from incretin mimetic drugs for type 2 diabetes" :

Emerging Drug Safety Issue: Possible Increased Risk Of Pancreatic Cancer With Byetta, Januvia, An ... [Published Drug Injury Watch - Mar 18 2013]

More Content

sort by: Date \| Relevance
Three New Type 2 Diabetes Treatment Options App... [Published Record Delta - May 13 2013]
Furiex Releases 1Q 2013 Financial Results [Published Individual.com - May 13 2013]
Which Came First? Alogliptin Avoids Possible Ex... [Published The Rose Sheet - May 11 2013]
Alleged Januvia Pancreatic Cancer Lawsuits Offe... [Published PRWeb - May 10 2013]
Furiex Reports First Quarter 2013 Financial Res... [Published Equities.com - May 10 2013]
Furiex Posts 1Q 2013 Financial Results [Published Individual.com - May 10 2013]
Furiex Reports First Quarter 2013 Financial Res... [Published Individual.com - May 10 2013]
Takeda rides out Actos decline as fiscal 2012 s... [Published PMLive - May 09 2013]
Furiex Pharmaceuticals Management Discusses Q1 ... [Published Seeking Alpha - May 09 2013]
Furiex Pharmaceuticals, Inc. (FURX) Reports Fir... [Published BioSpace - May 08 2013]
Furiex Pharmaceuticals, Inc. Reports First Quar... [Published BioSpace - May 08 2013]
Furiex Reports First Quarter 2013 Financial Res... [Published Reuters - May 07 2013]
Furiex Reports First Quarter 2013 Financial Res... [Published Investors Business Daily - May 07 2013]
False Friends: FDA’s “Gift” on NESINA – Present... [Published FDA Law Blog - May 03 2013]
New Findings from Keio University in Diabetes P... [Published NewsRX - May 03 2013]
Takeda and Sanofi Sign Co-promotion Agreement t... [Published Nycomed News RSS feed - Apr 22 2013]
More » Report Shows Byetta, Januvia and Other I... [Published Yahoo! News - Apr 20 2013]
Three New Type 2 Diabetes Treatment Options App... [Published Miami County Republic - Apr 16 2013]
Emerging Drug Safety Issue: Possible Increased ... [Published Drug Injury Watch - Mar 18 2013]
FDA Investigating Januvia, Byetta and Other Dia... [Published PRWeb - Mar 15 2013]
3 Attractively Valued Biotechs From BIO CEO 2013 [Published Healthcare Sector and Stocks Analysis from Seek ... - Feb 14 2013]
KAZANO (Alogliptin And Metformin Hydrochloride)... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013]
OSENI (Alogliptin And Pioglitazone) Tablet, Fil... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013]
OSENI (Alogliptin And Pioglitazone) Tablet, Fil... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]
NESINA (Alogliptin) Tablet, Film Coated [Takeda... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013]
OSENI (Alogliptin And Pioglitazone) Tablet, Fil... [Published DailyMed Drug Label Updates for the last seven ... - Feb 04 2013]
NESINA (Alogliptin) Tablet, Film Coated [Takeda... [Published DailyMed Drug Label Updates for the last seven ... - Feb 02 2013]
NESINA (Alogliptin) Tablet, Film Coated [Takeda... [Published DailyMed Drug Label Updates for the last seven ... - Jan 31 2013]
Three New Diabetes Drugs [Published ThirdAge - Jan 28 2013]
US FDA approves Takeda's diabetes drugs - Nesin... [Published PharmaBiz - Jan 28 2013]

Blogs

sort by: Date \| Relevance
False Friends: FDA’s “Gift” on NESINA – Present... [Published FDA Law Blog - May 03 2013] By Kurt R. Karst –Frau Rommelfanger’s seventh grade German class: that’s where we first learned to appreciate “false friends,” which are pairs of words or phrases in two languages that look or sound alike, but differ significantly in meaning. Never write ...
Emerging Drug Safety Issue: Possible Increased ... [Published Drug Injury Watch - Mar 18 2013] As "Pancreatitis Is On The Pathway Toward Pancreatic Cancer", Medical Studies Needed To Determine If GLP-1 Diabetes Medications Linked To Cancers Or Malignancies Involving Pancreas (Posted by Tom Lamb at DrugInjuryWatch.com ) We last wrote about ...
KAZANO (Alogliptin And Metformin Hydrochloride)... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013] Updated Date: Feb 6, 2013 EST ...
OSENI (Alogliptin And Pioglitazone) Tablet, Fil... [Published DailyMed Drug Label Updates for the last seven ... - Feb 06 2013] Updated Date: Feb 4, 2013 EST ...
OSENI (Alogliptin And Pioglitazone) Tablet, Fil... [Published DailyMed Drug Label Updates for the last seven ... - Feb 05 2013] Updated Date: Feb 4, 2013 EST ...

Press Releases

sort by: Date \| Relevance
Takeda and Sanofi Sign Co-promotion Agreement t... [Published Nycomed News RSS feed - Apr 22 2013]
Takeda Receives FDA Approval for Three New Type... [Published Nycomed News RSS feed - Jan 26 2013]
Furiex Confirms Takeda’s Receipt of FDA Approva... [Published EON Health & Medicine - Jan 26 2013]
Furiex Confirms Takeda’s Receipt of FDA Approva... [Published Business Wire Health News - Jan 26 2013]
Takeda Receives FDA Approval for Three New Type... [Published PR Newswire: General Business - Jan 25 2013]